EET increases BDNF expression via multiple promoters (I, II, and III) other than IV to compensate for the pIV-BDNF deficiency in the hippocampus, and reverses depression-like behaviors of KIV mice (Jha et al. 2011; Dong et al. 2018). Here, BDNF is linked to depressive disorder.